North Mountain Merger (FRA:92X) Research & Development: €0.00 Mil (TTM As of Jun. 2022)


FRA:92X North Mountain Merger Corp FRA:92X
22 GF Score
Price €10.20
View Full Analysis

What is North Mountain Merger Research & Development?

North Mountain Merger FRA:92X 22 Research & Development is €0.00 Mil as of Jun. 2022. GuruFocus rates FRA:92X with a GF Score™ of 22/100.

Research & Development is the aggregate amount of research and development expenses during the year. North Mountain Merger's Research & Development for the three months ended in Jun. 2022 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2022 was €0.00 Mil.

North Mountain Merger  (FRA:92X) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

North Mountain Merger Research & Development Related Terms

North Mountain Merger Research & Development Historical Data

* Premium members only.

The historical data trend for North Mountain Merger's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

North Mountain Merger Research & Development Chart

North Mountain Merger Annual Data
Trend Dec20 Dec21
Research & Development
0.00 0.00

North Mountain Merger Quarterly Data
Jul20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
FRA:92X
22GF Score
North Mountain Merger Corp FRA:92X
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

North Mountain Merger Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
North Mountain Merger (FRA:92X) has a Research & Development of €0.00 Mil as of Jun. 2022. Research and development expense is the total cost for research and development activities. View historical data on North Mountain Merger and its competitors.
Is North Mountain Merger's Research & Development too high?
North Mountain Merger's current Research & Development is €0.00 Mil. Overall, North Mountain Merger has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does North Mountain Merger's Research & Development compare to DMAQ and WAYS?
North Mountain Merger's Research & Development of €0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Diversified Financial Services company?
A good Research & Development depends on the Diversified Financial Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on North Mountain Merger and its competitors. North Mountain Merger's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is North Mountain Merger stock overvalued right now?
North Mountain Merger (FRA:92X) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. North Mountain Merger's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For North Mountain Merger (FRA:92X), the current Research & Development is €0.00 Mil as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

North Mountain Merger Business Description

Address 767 Fifth Avenue, 9th Floor, New York, NY, USA, 10153
North Mountain Merger Corp is a blank check company.
22GF Score

Get the complete analysis for FRA:92X

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.20
Price